NextCure Inc (NAS:NXTC)
$ 1.39 -0.04 (-2.8%) Market Cap: 38.88 Mil Enterprise Value: -40.56 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 39/100

NextCure Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 19, 2023 / 02:15PM GMT
Release Date Price: $1.55 (-2.52%)
Gil Blum
Needham & Company - Analyst

Hello, everyone, and thank you for joining me this morning at the third day of the Needham and Company Healthcare Conference. This morning, I have with me Michael Richman, the President and CEO of NextCure. Michael, with that, you have the stage.

Michael Richman
NextCure, Inc. - President & CEO

Great. Thank you so much, Gil, and thanks to the Needham team for including NextCure in the Annual Virtual Healthcare Conference this year. It's great to be with everyone and look forward to walking you through an update on NextCure and our approach towards treating cancer by restoring immune function.

This is our forward-looking statement on slide 2, and now moving into slide 3. This outlines the NextCure opportunity, which we think is quite unique even during these changing times. Our pipeline that I'll walk you through today is quite differentiated. We have three ongoing clinical programs based on novel targets and diverse indications. Each of those three programs will have readouts and updates in this year in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot